Pharmidex attending NCRI Cancer Conference 2018

October 23, 2018

The Pharmidex Oncology team will be attending the 2018 NCRI Cancer Conference in Glasgow, please visit us at Stand 19.

Pharmidex will attending this years NCRI conference in Glasgow. Our team will exhibiting at stand 19.

The NCRI Cancer Conference is the UK’s largest forum showcasing the latest advances in cancer research. The Conference provides a platform for researchers, clinicians, people affected by cancer and industry representatives to come together to discuss, present and showcase high-quality research. Informative and interactive educational sessions attract over 1,500 delegates each year and create the ideal setting to establish new collaborations with key stakeholders in cancer research.

For more information please see: https://conference.ncri.org.uk/

< Older Post

Newer Post >

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist

July 30, 2025

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist

🎓 Welcoming Future Scientists to Pharmidex! 🎓

July 28, 2025

We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩‍🔬 👨‍🔬 Welcome to the team, Gabrielle and Mohammed!

Does your compound taste good enough for the clinic?

July 24, 2025

At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.